Cineverse Corp. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Cineverse Corp. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	90.4	67.7	53.5	39.3	31.4	56.1	68	49.1	78.2	65.7
Cost of revenue						0.81
Gross profit						55.2
Selling, general and administrative	23.8	28.5	27.7	16.3	21.9	29.6	36.8	27.9	27.7	43.3
Selling and marketing								0.58	1.39	7.53
Operating expenses	83.6	67	59.2	43.6	44.9	57	76.9	64.8	70.3	80.9
Operating income	6.76	0.72	-5.62	-4.35	-13.5	-0.93	-8.92	-15.7	7.92	-15.2
Interest expense	19.1	14.3	10.3	7.26	4.09	0.36	1.29	1.07	4.37
Interest income				0.02	0.04	0
Other non-operating income	0.03	-0.28	-0.1	-1.21	-0.68	0	-0.01	-0.19	0.31	-0.14
Pre-tax income	-14.9	-18.1	-16	-14.4	-63.2	1.48	-9.58	-21.3	3.87	-11.5
Income tax	0.25	0.4	0.3	0.31	-0.32	-0.79	0.12	0.01	0.11	-2.84
Income from continuing operations	-15.2	-18.5	-16.3	-14.7
Net income to minority interests	-0.07	-0.04	-0.03	0.01	-0.09	0.06	0.04	0.14	0.16	0.18
Net income	-15.1	-18.5	-16.2	-14.7	-62.9	2.27	-9.69	-21.3	3.76	-8.66
EBITDA	40.2	18.7	8.13	5.04	-6.55	3.64	-5.09	-11.9	11.7	-9.18
EPS, basic	-38.40	-16.20	-8.80	-6.80	-9.80	0.21	-1.13	-1.78	0.18	-0.49
EPS, diluted	-38.40	-16.20	-8.80	-6.80	-9.80	0.20	-1.13	-1.78	0.16	-0.49
Shares, basic (weighted)	0.4	1.16	1.9	2.2	6.39	8.53	8.89	12.3	15.8	18.8
Shares, diluted (weighted)	0.4	1.16	1.9	2.2	6.39	8.69	8.89	12.3	17.8	18.8

Balance sheet

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Cash and equivalents	12.6	18	17.9	14.3	16.8	13.1	7.15	5.17	13.9	3.39
Receivables	53.6	38.1	35.5	34.8	21.1	30.8	20.8	15.1	15.8	38.6
Inventory	1.14	0.79	0.67	0.58	0.17	0.12	0.21
Other current assets	1.56	1.18	0.53	5.38	3.66	5.91	1.73	1.43	1.65	1.28
Total current assets	86.5	74.2	64.9	57	43.1	52.2	37.6	32.7	38.1	50.8
Property, plant and equipment	33.1	21.5	14	7.97	3.5	1.98	1.83	2.28	2.88	3.91
Lease right-of-use assets			0	1.21	0.1	0.75
Goodwill	8.7	8.7	8.7	8.7	8.7	21.1	20.8	6.8	6.8	21.2
Intangible assets	14.7	14.7	9.69	6.92	9.86	20	19.9	18.3	18.2	44.1
Other non-current assets				4.17	2.7	2.35	1.27	1.7	2.54	2.05
Total assets	121	121	98.8	110	75.4	105	88	64.4	72.5	130
Accounts payable	33.1	35	38.4	50.7	30.1	34.2	15	5.8	7.3	7.32
Accrued liabilities	1.06	2.28	3.1	1.24
Deferred revenue	2.46	1.82	1.69	1.65	0.92	0.2	0.23	0.44	0.18	0.13
Short-term debt	5.29	43.3	43.3	11.4	7.79
Total current liabilities	102	76.3	114	128	57.4	57	45.3	31.2	34.4	63
Long-term debt	63	19.1	19.1	0	2.15
Lease liabilities			0	0.68	0.01	0.49	0.86	0.46	0.28	0.11
Other non-current liabilities	0.41	0.31	0.21	0.11	0.02	0.49	0.07	0.06	0.01	0
Total liabilities	222	143	135	130	59.6	63.7	48.9	32.2	34.7	86.9
Total debt	68.3	62.5	62.5	11.4	7.79
Paid-in capital	287	366	369	401	499	523	531	546	548	564
Retained earnings	-360	-379	-396	-411	-474	-472	-482	-504	-501	-510
Treasury stock	0	-11.6	-11.6	-11.6	-11.6	-11.6	-11.6	-12	-12.2	-13.2
Other comprehensive income	-0.04	-0.04	0.01	0.09	-0.07	-0.16	-0.4	-0.35	-0.31	-0.28
Shareholders' equity	-69.5	-21	-35.3	-18	17.2	42.3	40.3	33.3	38.8	44.3
Minority interests	-1.21	-1.26	-1.29	-1.28	-1.36	-1.3	-1.26	-1.12	-0.96	-0.95
Total equity	-70.7	-22.3	-36.6	-19.3	15.9	41	39.1	32.2	37.8	43.4
Total liabilities and equity	151	121	98.8	110	75.4	105	88	64.4	72.5	130

Cash flow statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Net income	-15.2	-18.5	-16.3	-14.7	-62.9	2.27	-9.69	-21.3	3.76	-8.66
Depreciation and amortization	33.4	18	13.8	9.39	6.92	4.57	3.83	3.77	3.8	5.97
Stock-based compensation	1.73	2.28	1.58	0.54	2.89	5.49	4.47	1.44	1.93	2.99
Deferred income tax						-0.89			-0.01	-2.91
Change in receivables	-2.19	14.9	1.15	-0.03	13.7	-8.09	9.94	7.57	-0.62	-7.74
Change in inventory	0.51	0.74	0.21	0.5	0.41	0.05
Change in payables	5.93	-3.32	-0.54	7.98	-29.8	4.1	-18	-2.3	9.86	-6.39
Cash from operations	31.7	22.4	11.1	7.76	-20	4.88	-8.8	-10.6	17.4	-26.5
Capital expenditures					-6.49	-0.32	-1.27	-1.07
Acquisitions						-11.7			0	-9.97
Cash from investing	-0.49	-0.93	-1.97	-1.25	-1.71	-12.3	-1.27	-0.53	-0.64	-14.3
Debt issued	3.5	1.46	0
Debt repaid								0	-3.09	0
Stock issued		28	0	5.85	42.7	12.4		8.52	0	3.45
Share buybacks	0	-0.16	0			-4.83		0	-0.22	0
Cash from financing	-44.1	-16.1	-9.2	-10.1	24.3	2.64	4.16	9.14	-8	30.2
Exchange rate effect									0.04	0.02
Net change in cash	-12.9	5.39	-0.08	-3.58	2.56	-4.79	-5.91	-1.99	8.73	-10.6
Free cash flow					-26.5	4.56	-10.1	-11.7
Interest paid	16.5	13.9	8.63	4.91	4.05	0.78	0.2	0.38	1	0.67
Income taxes paid	0.32	0.4	0.27	0.44	0.23	0.08	0.1	0.06	0.03	0.07

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $2.02 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Operating margin	-19.5%	Operating income / revenue.
EBITDA margin	-10.4%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	-16.0%	Pre-tax income / revenue.
Net margin	-12.7%	Net income / revenue.
Operating cash flow margin	-15.4%	Cash from operations / revenue.
Return on equity (ROE)	-27.0%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	-8.0%	Net income / average total assets.
Return on invested capital (ROIC)	-36.6%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	54.0%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	4.1%	Stock-based compensation (from the cash flow statement) / revenue.
D&A / revenue	9.1%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-15.9%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-1.1%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	15.9%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-291.3%	Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y	-178.4%	EBITDA vs the same period a year earlier. Only from a positive base.
Net income growth, 1y	-330.0%	Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y	-406.3%	EPS vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y	-252.5%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Book value growth, 1y	14.4%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	3.2%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	20.8%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	79.7%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	14.0%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	11.5%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	5.4%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	28.3%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	24.1%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	0.75x	Current assets / current liabilities.
Quick ratio	0.64x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.06x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	70.4%	Total liabilities / total assets.
Working capital	-$18.9M	Current assets - current liabilities.
Goodwill and intangibles / assets	46.8%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$23.1M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.63x	Revenue / average total assets.
Fixed asset turnover	20.5x	Revenue / average property, plant and equipment.
Receivables turnover	1.98x	Revenue / average receivables.
Days sales outstanding	184 days	365 x average receivables / revenue.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$0.52	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$4.12	Revenue / diluted weighted shares.
Operating cash flow per share	-$0.64	Cash from operations / diluted weighted shares.
Book value per share	$1.94	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$1.12	Tangible book value / shares outstanding.
Cash per share	$0.21	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$48.0M	Share price x shares outstanding.
Enterprise value	$43.7M	Market cap + total debt - cash - short-term investments.
P/S	0.56x	Market cap / revenue.
P/B	1.20x	Market cap / shareholders' equity. Only when equity is positive.
EV/Sales	0.51x	Enterprise value / revenue.
Earnings yield	-22.6%	Net income / market cap (the inverse of P/E).

What was Cineverse Corp.'s revenue in fiscal 2026?

Cineverse Corp. reported revenue of $65.7M for fiscal 2026, 15.9% lower than the year before.

Was Cineverse Corp. profitable in fiscal 2026?

No. It reported a net loss of $8.7M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Cineverse Corp.